Search the Newsreel

Nexxen International Ltd. Revenue Breakdown – NASDAQ:NEXN

This article provides a revenue breakdown for Nexxen International Ltd. (NASDAQ: NEXN), highlighting that the company generated $353.13 million USD last year. Its top-performing segment, Programmatic, contributed $340.63 million USD, and the United States was the greatest regional contributor with $334.45 million USD.

Crexendo (NASDAQ: CXDO) CEO converts RSUs, uses shares to pay taxes

Crexendo (NASDAQ: CXDO) CEO Jeffrey G. Korn reported the vesting of 1,666 Restricted Stock Units (RSUs) on July 25 and 27, 2026, which converted into common stock. To cover payroll taxes, the company withheld 407 shares, valued at $6.62 and $6.92 per share, a …

Form 4 Crexendo For: 28 July By Investing.com

This article from Investing.com reports on a Form 4 filing for Crexendo (CXDO) on July 28. It appears to be a brief update on insider transactions or ownership changes for the company. The article contains minimal content beyond the headline and links, likely serving …

Crexendo, Inc. (CXDO) CFO reports RSU vesting and tax share withholding

Crexendo, Inc.'s CFO, Vincent Ron, reported the vesting and conversion of 1666 RSU awards into common stock on July 25 and July 27, 2026. The company withheld 707 shares at $6.62 and $6.92 each to cover payroll taxes, which are explicitly stated not to …

Crexendo, Inc. (CXDO) COO gets 1,666 RSU shares, 456 withheld

Crexendo, Inc. COO Douglas Walter Gaylor reported the vesting of 1,666 Restricted Stock Units (RSUs) on July 25 and 27, 2026, which converted into common stock. Concurrently, 456 shares were withheld by the company to cover payroll taxes, at prices of $6.62 and $6.92 …

Nexxen International (NEXN) insider files to sell 17,578 shares under Rule 144

Nexxen International Ltd. (NEXN) announced a proposed sale of 17,578 ordinary shares by an insider under Rule 144, valued at approximately $180,174.50, to be executed through Oppenheimer & Co. Inc. on Nasdaq. The filing indicates 56,284,083 ordinary shares outstanding and notes that 75,386 ordinary …

Xenetic Biosciences, Inc. Revenue Breakdown – MUN:3XB0

This article provides a revenue breakdown for Xenetic Biosciences, Inc. (MUN:3XB0), highlighting the United States as its primary revenue source. In the last year, the U.S. contributed €2.53 million, closely following €2.42 million from the previous year. The information is presented within the context …

Crexendo (CXDO) to Post Quarterly Earnings on Tuesday

Crexendo (NASDAQ:CXDO) is scheduled to release its Q2 2026 earnings after market close on Tuesday, August 4th, with analysts forecasting earnings of $0.11 per share on revenue of $24.64 million. The company's previous quarter saw it beat estimates with $0.10 EPS and $20.71 million …

Crexendo Inc (CXDO) Institutional Confidence

Crexendo Inc (CXDO) has an institutional shareholding score of 3.00, placing it 283rd out of 485 in the Software & IT Services industry. The institutional shareholding proportion recently increased by 7.19% quarter-over-quarter, reaching 28.90%. The largest institutional investor, Bill Nygren | OAKMX, holds 439.67K …

CXDO|Crexendo Inc|Price:6.840|Chg%:-0.030

This article provides a comprehensive stock analysis of Crexendo Inc (CXDO), highlighting its strong fundamentals, high growth potential, and fair valuation within the Software & IT Services industry. The company's stock score is 6.25/10, with analysts rating it a "Buy" and expecting an upside …

Crexendo Inc (CXDO) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Crexendo Inc (CXDO), stating its current valuation score is 5.45, ranking it 434 out of 485 in the Software & IT Services industry. It highlights the company's P/E ratio of 45.32, noting it is significantly divergent from …

Crexendo Inc (CXDO) Financial Health: Profitability & Balance Sheet Analysis

Crexendo Inc (CXDO) has a robust financial health score of 8.62, ranking 67 out of 486 in the Software & IT Services industry, despite average operating efficiency. The company reported a 28.98% year-over-year revenue increase to $20.71 million and a 50.64% increase in net …

Xenetic Biosciences Inc (XBIO) Financial Health: Profitability & Balance Sheet Analysis

Xenetic Biosciences Inc (XBIO) has a strong financial health score of 8.45, ranking 44th in the Biotechnology & Medical Research industry. The company reported a significant year-over-year revenue increase of 36.01% to $806.92K and a net profit increase of 49.47%. Despite its robust financial …

Nexxen International Ltd (NEXN) Institutional Confidence

Nexxen International Ltd (NEXN) has an institutional shareholding score of 3.00, placing it 47th out of 77 in the Media & Publishing industry. The institutional shareholding decreased by 8.09% quarter-over-quarter, with the largest shareholder, James Simons, holding 0.45% of outstanding shares. Major institutional shareholders …

Xenetic Biosciences Inc (XBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Xenetic Biosciences Inc (XBIO). It indicates that the company has not distributed any dividends in the past five years. However, it lists a 10-to-1 merger-related stock split event that occurred on May …

XENIA HOTELS & RESORTS ANNOUNCES TIMING OF SECOND QUARTER 2022 E

Xenia Hotels & Resorts announced the timing for its second quarter 2022 earnings release and conference call. The announcement, distributed via PR Newswire, indicates the company will be sharing its financial results for the quarter. This news is relevant for investors tracking the performance …

Xenia Hotels & Resorts, Inc. Revenue Breakdown – NYSE:XHR

Xenia Hotels & Resorts, Inc. (NYSE: XHR) generated 1.08 billion USD in revenue in the last year. The "Rooms" segment was the top-performing section, contributing 596.54 million USD, while the United States was the primary geographical contributor. The article provides a breakdown of the …

Xenon Pharmaceuticals Inc (XENE) Institutional Confidence

Xenon Pharmaceuticals Inc (XENE) has an institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. Institutional ownership stands at 116.66%, a 21.96% increase quarter-over-quarter. Paul Tudor Jones is the largest institutional shareholder, holding 534.69K shares, which represents 0.51% …

Xenon Pharmaceuticals Inc (XENE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Xenon Pharmaceuticals Inc (XENE) shareholder structure, listing major shareholders, their proportion of holdings, and a classification of shareholder types. It also includes institutional shareholding trends over several quarters and recent shareholder activity with changes in holdings for …

Crexendo Inc (CXDO) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of Crexendo Inc (CXDO) dividends and stock splits. It details the company's dividend distribution over the past five years, totaling $592,000 USD, and lists specific interim cash dividend payments with their record, payment, and ex-dividend dates. The current …

Xencor Inc (XNCR) Cash Flow

This article presents the detailed cash flow statements for Xencor Inc (XNCR), breaking down operating, investing, and financing activities across various quarterly and annual periods. It includes financial figures for net income, capital expenditures, and changes in working capital, allowing users to analyze the …

Xencor Inc (XNCR) Income Statement

This article presents the quarterly and annual income statements for Xencor Inc (XNCR), offering detailed financial data from FY2012Q4 to FY2026Q1, including total revenue, operating expenses, net income, and earnings per share. It allows users to analyze the company's financial performance and operational efficiency …

NEXN|Nexxen International Ltd|Price:10.450|Chg%:+0.200

This TradingKey analysis of Nexxen International Ltd (NEXN) highlights its strong fundamentals, high growth potential, and fair valuation at $10.447. The stock scores 6.25/10, ranking 25th in the Media & Publishing industry, with high institutional ownership and a "Buy" rating from multiple analysts. Currently, …

Xenetic Biosciences Inc (XBIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown of Xenetic Biosciences Inc (XBIO), noting that relevant data regarding business segments, regional revenue, and profit contribution has not been disclosed by the company. It highlights the current stock price, market capitalization, and indicates a lack of detailed …

Xenon Pharmaceuticals Inc (XENE) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Xenon Pharmaceuticals Inc (XENE) stock, focusing on its dividend and stock split history. It notes that the company has distributed a total of $0.00 in dividends over the past five years, indicating no payout history. The page also …

XBIO|Xenetic Biosciences Inc|Price:2.550|

Xenetic Biosciences Inc. (XBIO) is a biopharmaceutical company focused on immuno-oncology technologies, specifically advancing its Deoxyribonuclease (DNase) technology to treat difficult cancers. The company's DNase technology targets neutrophil extracellular traps (NETs) to improve existing cancer treatments, including immunotherapies. XBIO is developing this technology for …

Xencor Inc (XNCR) Balance Sheet

This article provides Xencor Inc's (XNCR) balance sheet data, allowing users to evaluate the company's financial health, fundamentals, and key ratios. It includes quarterly financial data for assets, liabilities, and shareholders' equity, along with an FAQ section explaining key balance sheet metrics and their …

Xencor Inc (XNCR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Xencor Inc's (XNCR) shareholder structure, listing major institutional holders and their percentage of ownership. It also categorizes shareholders by type and presents a history of institutional shareholdings and recent activity. Additionally, the article lists various ETFs that …

Xenetic Biosciences Inc (XBIO) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Xenetic Biosciences Inc (XBIO), identifying major individual and institutional holders. It provides a breakdown of shareholder types, including hedge funds, corporations, and individual investors, and lists institutional shareholding changes over several quarters. Key investors like Renaissance Technologies …

TradingKey

This article provides a detailed quarterly and annual income statement for Xenetic Biosciences Inc (XBIO) through FY2026Q1, emphasizing key financial metrics like total revenue, operating expenses, and net income. It also includes frequently asked questions about how to interpret these financial statements on the …

Xenora Minerals Ltd (XRA) News Flow

XNCR|Xencor Inc|Price:22.739|Chg%:-0.251

XNCR|Xencor Inc|Price:21.635|Chg%:+0.825

Crexendo Inc (CXDO) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Crexendo Inc (CXDO), listing major individual and institutional holders and their respective proportions. It also breaks down shareholder types and provides a history of institutional shareholding over recent quarters, alongside related ETF information.

Crexendo Inc (CXDO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Crexendo Inc (CXDO) by business segment and geographical region. It highlights that telecommunications services and subscription maintenance and support are the largest revenue contributors, and the United States accounts for the vast majority of the company's …

Nexxen International Ltd (NEXN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nexxen International Ltd (NEXN), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 4.53 and is trading between a resistance level …